A new tool can diagnose sepsis in less than fifteen minutes, even with a very low concentration of biomarkers.
Convolutional neural networks provide stronger predictive performances for pharmacological assays compared to traditional machine learning models.
Older individuals in low- and middle-income countries are considered to be the most vulnerable to COVID-19 but have yet to be properly acknowledged in global planning for the disease.
One drug, three modes of action: Clinicians combat the drug resistances of some cancer types by using a combination of different drugs.
Researchers from Freie Universität Berlin explore the impact of 3D pharmacophores on drug discovery, as well as recent developments in the field.
Archimedean spirals for flexible heat actuator-sensor devices.
Scientists feed live microalgal cells terbium to fabricate 3D functional devices.
Scientists pave way for nanobots to one day diagnose and treat disease with the first DNA-based motor to run on chemical energy.
Researchers at UCL and Imperial College London debate whether the British pharmaceutical industry, like their healthcare industry, should be nationalized.
A new take on CRISPR allows researchers to “paint” cells and observe never-before-seen cellular processes in great detail.
Artificial enzymes promise to not only help us understand the complex functioning of enzymes, but will create a new generation of biosystems for sustainable chemistry practices.
Living cells are capable of synthesizing a staggering number of complex molecules from a few precursors. Such processes in natural materials allow for continuous, efficient, and autonomous (re)generation and adaptation in response to external factors. These properties...